The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Post-ATU Study of Nivolumab
- Status
- COMPLETED
- Phase
- N/A
Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV
- Status
- COMPLETED
- Phase
- N/A
REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
French Clinical Datbase of Melanoma Patients (RIC-Mel)
- Status
- RECRUITING
- Phase
- N/A
Uptake and Biodistribution of 89Zirconium-labeled Ipilimumab in Ipilimumab Treated Patients With Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Screening for Atrial Fibrillation (AF)-Potential Patients to Increase AF Detection Rate
- Status
- COMPLETED
- Phase
- N/A
An Investigational Study to Assess the Effect of a Light Meal and a High-Fat Meal on the Absorption of BMS-986205 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab/Ipilimumab-Primed Immunotransplant for DLBCL
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months (NiCOL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
- Status
- RECRUITING
- Phase
- PHASE2
BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy
- Status
- COMPLETED
- Phase
- PHASE2
Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1